MRK

#39
Merck & Co., Inc.
120.22 USD
-0.99%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
119.82
120.35
Jahresspanne
73.31
125.14
Tagesänderung
-0.99%
Monatliche Änderung
+4.23%
6 month change
+40.79%
Jahresänderung
+50.24%
Vorheriger Schlusskurs
121.42
Eröffnung
119.95
Bid
Ask
Tief
119.82
High
120.35
Volumen
1 109
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 297.23 B
  • Employee 75 K
  • Founded N/A
  • CEO Robert M Davis
  • Website www.merck.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BPD168
  • Industry Technology
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
14.46
Preis-Umsatz-Verhältnis
4.06
Dividende je Aktie
3.28
Dividendenrendite in %
3.12

Merck & Company Inc (new)

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck".

Nachrichten